期刊文献+

重组人血管内皮抑素对食管癌细胞的放射增敏作用及其机制 被引量:10

Effect of recombinant human endostatin on the radiosensitivity of esophageal carcinoma cells and underlying mechanism
原文传递
导出
摘要 目的 观察重组人血管内皮抑素(rhES)对食管鳞癌KYSE-150细胞的放射敏感性的影响及其机制的初步探讨.方法 将食管鳞癌KYSE-150细胞分为空白对照组、rhES组、X射线照射组和rhES联合X射线照射组.细胞克隆形成法测定细胞存活分数;单击多靶模型拟合细胞存活曲线并计算放射增敏比(SER);流式细胞术检测rhES联合X射线照射对细胞周期及凋亡的影响;反转录聚合酶链反应(RT-PCR)检测Cyclin B1、Cyclin D1、Bcl-2、Bax mRNA表达水平,Western blot检测HIF-1α、VEGF、VEGFR蛋白的表达水平.结果 KYSE-150细胞的Do、Dq、SF2值随着rhES浓度的增加逐渐减小,当达到Do照射剂量时,100和200 μg/ml rhES的放射增敏比分别为1.14、1.27;rhES联合X射线照射组与X射线照射组比较,细胞凋亡率增加、凋亡相关基因bax的表达增加、细胞VEGF蛋白及HIF-1α蛋白的表达水平降低(t=7.97、3.02、117.55、7.22,P<0.05).结论 rhES对体外食管癌细胞具有明显的辐射增敏作用,其机制与其抑制细胞HIF-1 α、VEGF蛋白表达以及对细胞凋亡相关基因bax的表达调控、诱导细胞凋亡密切相关. Objective To study the effect of recombinant human endostatin (rhES)on the radiosensitivity of esophageal squamous cells KYSE-150 and its preliminary mechanism.Methods Cells were divided into four groups:control group without treatment,rhES group treated with recombinant human endostatin,radiation alone group exposed with X-rays,and combination group exposed with X-rays plus endostatin.Colony formation assay was used to measure cell survival fraction.A single-hit multi-target model was used to fit cell survival curve and calculate the sensitive enhancement ratio (SER).Influence of rhES combined with X-ray radiation on cell cycle and apoptosis was measured by flow cytometry.Expressions of Cyclin B1,Cyclin D1,Bcl-2 and Bax mRNAs were determined by RT-PCR.Protein expressions of HIF-1α,VEGF,and VEGFR were determined by Western blot.Results D0,Dq and SF2 value of KYSE-150 cells decreased along with the concentration of rhES.At D0dose,the SER for 100 and 200 μg/ml rhES was 1.14 and 1.27,respectively.Compared with the radiation alone group,the apoptosis rate and bax expression increased,while the expressions of VEGF and HIF-1α decreased in the combination group (t =7.97,3.02,117.55,7.22,P 〈 0.05).Conclusions rhES has radiosensitive effect on esophageal carcinoma cells KYSE-150 in vitro by inhibiting the expressions of HIF-1α and VEGF,regulating bax expression,and inducing apoptosis.
出处 《中华放射医学与防护杂志》 CAS CSCD 北大核心 2013年第4期346-350,共5页 Chinese Journal of Radiological Medicine and Protection
基金 江苏省卫生厅指导性科研项目(Z201220) 常州市卫生局重大项目(ZD201105) 常州市科技支撑社会发展项目(CE20125021)
关键词 重组人血管内皮抑素 食管癌细胞 辐射敏感性 Recombinant human endostatin Esophageal carcinoma cells Radiosensitivity
  • 相关文献

参考文献16

  • 1汲振余,赵立群,杨观瑞,索振河,JahnM.Nesland,彭迁.HIF-1α在食管上皮细胞中的诱导表达及对光动力疗法的影响[J].肿瘤,2006,26(6):507-511. 被引量:3
  • 2Karamouzis, MV, Moschos SJ. The use of endostatin in the treatment of solid tumors. Expert Opin Bioi Ther, 2009, 9 (5) : 641-648.
  • 3Semenza GL. HIF -1 and mechanisms of hypoxia sensing. Curr Opin Cell Bioi, 2001, 13 (2) : 167 -171.
  • 4Cummins EP, Taylor CT. Hypoxia-responsive transcription factors. Pflugers Arch, 2005, 450 (6) : 363 -371.
  • 5Hanna NN, Seetharam S, Mauceri HJ, et al. Antitumor interaction of short-course endostatin and ionizing radiation. Cancer, 2000, 6 (5) : 287 -293.
  • 6Itasaka S, Komaki R, Herbst RS, et al. Endostatin improves radioresponse and blocks tumor revascularization after therapy for A431 xenografts in mice. IntJ Radiat Oncol Bioi Phys, 2007, 67 (3) :870-878.
  • 7Yoon MS, Nam TK, LeeJS, et al. VEGF as a predictor for response to definitive chemoradiotherapy and COX-2 as a prognosticator for survival in esophageal squamous cell carcinoma.J Korean Med Sci, 2011, 26(4) :513-520.
  • 8Takala H, Saarnio 1. Wiik H, et al. HIF -1 a and VEGF are associated with disease progression in esophageal carcinoma.J Surg Res, 2011, 167(1) :41-48.
  • 9Tzao C, Lee SC, Tung HJ, et al. Expression of hypoxia?inducible factor (HIF) -1 a and vascular endothelial growth factor ( VEGF ) -D as outcome predictors in resected esophageal squamous cell carcinoma. Dis Markers, 2008, 25 ( 3 ) : 141-148.
  • 10Yu'JP, Liu FJ, Sun ZQ, et al. The enhancement of radiosensitivity in human esophageal carcinoma cells by thalidomide and its potential mechanism. Cancer Biother Radiopharm, 2011 , 26(2) :219-227.

二级参考文献24

  • 1PENG Q, WARLOE T, BERG K,et al. 5-Aminolevulinic acid-based photodynamic therapy:Clinical research and future challenges[J]. Cancer,1997,79(12):2282-2308.
  • 2DOUGHERTY J J, GOMER C J, HENDERSON B W, et al.Review:Photodynamic therapy[J]. J Natl Cancer Inst , 1998,90(12):889-905.
  • 3SEMENZA G L. Hypoxia inducible factor 1:master regulator of O2 homeostasis[J]. Curr Opin Genet Dev, 1998,8(5):588-594.
  • 4SCHMIDT,ZHOUJ,BRUNEB. HIF-1 and p53:communication of transcription factors under hypoxia[J]. J Cell Mol Med ,2004,8(4):423-431.
  • 5VAUPEL P, MAYER A. Hypoxia and anemia: effects on tumor biology and treatment resistance[J]. Transfus Clin Biol, 2005,12(1):5-10.
  • 6HARRISON L,BLACKWELL K. Hypoxia and anemia: factors in decreased sensitivity to radiation therapy and chemotherapy[J]. Oncologist, 2004,9 Suppl 5:31-40.
  • 7PENG Q,MOAN J,WARLOE T,et al. Build-up of esterified aminolevulinic-acid-derivative-induced porphyrin fluorescence in normal mouse skin[J]. J Photocchem Photobiol B, 1996,34(1):95-96.
  • 8BROWNSB,BROWN EA,WALKER I. The present and future role of photodynamic therapy in cancer treatment[J].Lancet Oncol,2004,5(8):497-508.
  • 9HARRIS A L. Hypoxia: a key regulatory factor in tumour growth[J]. Nat Rev Cancer ,2002,2( 1 ):38-47.
  • 10ZHONG H,De MARZO AM,LAUGHNER E,et al. Overexpression of hypoxia inducible factor 1 alpha in common human cancers and their metastases[J]. Cancer Res, 1999, 59 (22):5830-5835.

共引文献13

同被引文献51

引证文献10

二级引证文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部